Estrogen modulates in vitro T cell responses in a concentration- and receptor-dependent manner: Effects on intracellular molecular targets and antioxidant enzymes

Molecular Immunology

Volumn 56, Issue 4, 2013, Pages 328-339

  Priyanka, Hannah P ^a   Krishnan, Harini C ^a   Singh, Ran Vijay ^a   Hima, Lalgi ^a   ThyagaRajan, Srinivasan ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

17 Estradiol; Akt; CREB; Cytokine; ERK; Estrogen receptor; Nitric oxide

Indexed keywords

ANTIOXIDANT; CATALASE; CONCANAVALIN A; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PROTEIN KINASE B; SUPEROXIDE DISMUTASE; TAMOXIFEN; 1,3,5-TRIS(4-HYDROXYPHENYL)-4-PROPYL-1H-PYRAZOLE; ANTIESTROGEN; CYTOKINE; DIARYLPROPIONITRILE; ESTROGEN; GLUTATHIONE PEROXIDASE 1; NITRILE; PHENOL DERIVATIVE; PROPIONIC ACID DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LEVEL; CELL TYPE; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOMODULATION; IN VITRO STUDY; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN CELL; T LYMPHOCYTE; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; INTRACELLULAR SPACE; METABOLISM; SPLEEN; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; CATALASE; CELL PROLIFERATION; CELLS, CULTURED; CONCANAVALIN A; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; GLUTATHIONE PEROXIDASE; INTRACELLULAR SPACE; NITRIC OXIDE; NITRILES; PHENOLS; PROPIONATES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; SUPEROXIDE DISMUTASE; T-LYMPHOCYTES; TAMOXIFEN;

EID: 84881096129     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.05.226     Document Type: Article

References (51)

1. Abbas A.M., Elsamanoudy A.Z. Effects of 17β-estradiol and antioxidant administration on oxidative stress and insulin resistance in ovariectomized rats. Canadian Journal of Physiology and Pharmacology 2011, 89:497-504.
2. Bebo B.F., Fyfe-Johnson A., Adlard K., Beam A.G., Vandenbark A.A., Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. Journal of Immunology 2001, 166:2080-2089.
3. Benz C.C. Impact of aging on the biology of breast cancer. Critical Reviews in Oncology/Hematolog 2008, 66:65-74.
4. Bourque M., Dluzen D.E., Di Paolo T. Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease. Frontiers in Neuroendocrinology 2012, 33:169-178.
5. Brann D., Raz L., Wang R., Vadlamudi R., Zhang Q. Oestrogen signalling and neuroprotection in cerebral ischaemia. Journal of Neuroendocrinology 2012, 24:34-47.
6. Brown G.C. Nitric oxide and neuronal death. Nitric Oxide 2010, 23:153-165.
7. Castro-Caldas M., Mendes A.F., Duarte C.B., Lopes M.C. Dexamethasone-induced and estradiol-induced CREB activation and annexin 1 expression in CCRF-CEM lymphoblastic cells: evidence for the involvement of cAMP and p38 MAPK. Mediators of Inflammation 2003, 12:329-337.
8. Cunningham M., Gilkeson G. Estrogen receptors in immunity and autoimmunity. Clinical Reviews in Allergy & Immunology 2011, 40:66-73.
9. Cutolo M., Sulli A., Capellino S., Villaggio B., Montagna P., Seriolo B., Straub R.H. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004, 13:635-638.
10. Delpy L., Douin-Echinard V., Garidou L., Bruand C., Saoudi A., Guéry J.C. Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. Journal of Immunology 2005, 175:5050-5057.
11. Ellman G.L. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 1959, 82:70-77.
12. Fox H.S., Bond B.L., Parslow T.G. Estrogen regulates the IFN-gamma promoter. Journal of Immunology 1991, 146:4362-4367.
13. Gilmore W., Weiner L.P., Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. Journal of Immunology 1997, 158:446-451.
14. González D.A., Díaz B.B., Rodríguez Pérez Mdel C., Hernández A.G., Chico B.N., de León A.C. Sex hormones and autoimmunity. Immunology Letters 2010, 133:6-13.
15. Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clinica Chimica Acta 1991, 196:143-151.
16. Gourdy P., Araujo L.M., Zhu R., Garmy-Susini B., Diem S., Laurell H., Leite-de-Moraes M., Dy M., Arnal J.F., Bayard F., Herbelin A. Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-gamma production by invariant natural killer T cells. Blood 2005, 105:2415-2420.
17. Hildebrand F., Hubbard W.J., Choudhry M.A., Thobe B.M., Pape H.C., Chaudry I.H. Are the protective effects of 17beta-estradiol on splenic macrophages and splenocytes after trauma-hemorrhage mediated via estrogen-receptor (ER)-alpha or ER-beta?. Journal of Leukocyte Biology 2006, 79:1173-1180.
18. Kanda N., Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. Journal of Allergy and Clinical Immunology 1999, 103:282-288.
19. Karpuzoglu E., Fenaux J.B., Phillips R.A., Lengi A.J., Elvinger F., Ansar Ahmed S. Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: role of interferon-gamma. Endocrinology 2006, 147:662-671.
20. Karpuzoglu-Sahin E., Hissong B.D., Ansar Ahmed S. Interferon-gamma levels are upregulated by 17-beta-estradiol and diethylstilbestrol. Journal of Reproductive Immunology 2001, 52:113-127.
21. Kawasaki T., Suzuki T., Choudhry M.A., Bland K.I., Chaudry I.H. Salutary effects of 17beta-estradiol on Peyer's patch T cell functions following trauma-hemorrhage. Cytokine 2010, 51:166-172.
22. Koh K.K. Effects of estrogen on the vascular wall: vasomotor function and inflammation. Cardiovascular Research 2002, 55:714-726.
23. Lang T.J. Estrogen as an immunomodulator. Clinical Immunology 2004, 113:224-230.
24. Lannigan D.A. Estrogen receptor phosphorylation. Steroids 2003, 68:1-9.
25. Lebesgue D., Chevaleyre V., Zukin R.S., Etgen A.M. Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection. Steroids 2009, 74:555-561.
26. Li J., McMurray R.W. Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice. International Immunopharmacology 2006, 6:1413-1423.
27. Lu G., Shimizu I., Cui X., Tonga M., Tamaki K., Fokine H., Inoue H., Honda H., Ito S. Interferon-alpha enhances biological defense activities against oxidative stress in cultured rat hepatocytes and hepatic stellate cells. Journal of Investigative Medicine 2002, 49:172-181.
28. Maret A., Coder J.D., Garidou L., Fours G., Gourdy P., Crust A., DuPont S., Champion P., Duet P., Bayard F., Guéry J.C. Estradiol enhances primary antigen-specific CD4T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. European Journal of Immunology 2003, 33:512-521.
29. McLean R.R. Proinflammatory cytokines and osteoporosis. Current Osteoporosis Reports 2009, 7:134-139.
30. McMurray R.W., Ndebele K., Hardy K.J., Jenkins J.K. 17-beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 2001, 14:324-333.
31. Mohankumar P.S., Thyagarajan S., Quadri S.K. Correlations of catecholamine release in the medial preoptic area with proestrous surges of luteinizing hormone and prolactin: effects of aging. Endocrinology 1994, 135:119-126.
32. Moulton V.R., Holcomb D.R., Zajdel M.C., Tsokos G.C. Estrogen upregulates cyclic AMP response element modulator α expression and downregulates interleukin-2 production by human T lymphocytes. Molecular Medicine 2012, 18:370-378.
33. Murray R.W. Estrogen, prolactin, and autoimmunity: actions and interactions. International Immunopharmacology 2001, 1:995-1008.
34. Priyanka H.P., Bala P., Ankisettipalle S., ThyagaRajan S. Bacopa monnieri and L-deprenyl differentially enhance the activities of antioxidant enzymes and the expression of tyrosine hydroxylase and nerve growth factor via ERK 1/2 and NF-(B pathways in the spleen of female Wistar rats. Neurochemical Research 2013, 38(1):141-152.
35. Priyanka H.P., Singh R.V., Mishra M., Thyagarajan S. Diverse age-related effects of Bacopa monnieri and donepezil in vitro on cytokine 6 production, antioxidant enzyme activities, and intracellular targets in splenocytes of F344 male rats. International Immunopharmacology 2013, 15(2):260-274.
36. Priyanka H.P., Sharma U., Gopinath S., Sharma V., Hima L., ThyagaRajan S. Menstrual cycle and reproductive aging alters immune reactivity, NGF expression, antioxidant enzyme activities, and intracellular signaling pathways in the peripheral blood mononuclear cells of healthy women. Brain, Behavior, and Immunity 2013, (in press). 10.1016/j.bbi.2013.03.008.
37. Prossnitz E.R., Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nature Reviews Endocrinology 2011, 7:715-726.
38. Salem M.L. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Current Drug Targets - Inflammation & Allergy 2004, 3:97-104.
39. Simpkins J.W., Green P.S., Gridley K.E., Singh M., de Fiebre N.C., Rajakumar G. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. American Journal of Medicine 1997, 103:19S-25S.
40. Stirone C., Duckles S.P., Krause D.N., Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Molecular Pharmacology 2005, 68:959-965.
41. Sun M., Zigman S. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Analytical Biochemistry 1978, 90:81-89.
42. Suzuki T., Yu H.P., Hsieh Y.C., Choudhry M.A., Bland K.I., Chaudry I.H. Mitogen activated protein kinase (MAPK) mediates non-genomic pathway of estrogen on T cell cytokine production following trauma-hemorrhage. Cytokine 2008, 42:32-38.
43. Titolo D., Mayer C.M., Dhillon S.S., Cai F., Belsham D.D. Estrogen facilitates both phosphatidylinositol 3-kinase/Akt and ERK1/2 mitogen-activated protein kinase membrane signaling required for long-term neuropeptide Y transcriptional regulation in clonal, immortalized neurons. Journal of Neuroscience 2008, 28:6473-6482.
44. Thomas W., Coen N., Faherty S., Flatharta C.O., Harvey B.J. Estrogen induces phospholipase A2 activation through ERK1/2 to mobilize intracellular calcium in MCF-7 cells. Steroids 2006, 71(3):256-265.
45. ThyagaRajan S., Madden K.S., Kalvass J.C., Dimitrova S.S., Felten S.Y., Felten D.L. l-Deprenyl-induced increase in IL-2 and NK cell activity accompanies restoration of noradrenergic nerve fibers in the spleens of old F344 rats. Journal of Neuroimmunology 1998, 92:9-21.
46. ThyagaRajan S., Madden K.S., Teruya B., Stevens S.Y., Felten D.L., Bellinger D.L. Age-associated alterations in sympathetic noradrenergic innervation of primary and secondary lymphoid organs in female Fischer 344 rats. Journal of Neuroimmunology 2011, 233:54-64.
47. ThyagaRajan S., MohanKumar P.S., Quadri S.K. Cyclic changes in the release of norepinephrine and dopamine in the medial basal hypothalamus: effects of aging. Brain Research 1995, 689:122-128.
48. White C.W., Ghezzi P., McMahon S., Dinarello C.A., Repine J.E. Cytokines increase rat lung antioxidant enzymes during exposure to hyperoxia. Journal of Applied Physiology 1989, 66:1003-1007.
49. Wiseman H., Rice-Evans C., Halliwell B. Antioxidant benefits of tamoxifen therapy for breast cancer?. Breast Cancer Research and Treatment 1994, 29(3):307.
50. Wiseman H., Laughton M.J., Arnstein H.R., Cannon M., Halliwell B. The antioxidant action of tamoxifen and its metabolites. Inhibition of lipid peroxidation. FEBS Letters 1990, 263(2):192-194.
51. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochemical Medicine 1976, 15:212-216.